| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/25/2002 | CN1371416A Human CTLA-4 antibodies and their uses |
| 09/25/2002 | CN1371390A Human G-protein coupled receptor |
| 09/25/2002 | CN1371389A 疫苗 Vaccine |
| 09/25/2002 | CN1371286A Use of cyclooxygenase-2 inhibitor matrix metallappoteinase inhibitor antineoplastic agent and optionally radiation as combination treatment of neoplasia |
| 09/25/2002 | CN1370843A Functions of Tob gene in central nervous system of mammol and its application |
| 09/25/2002 | CN1370832A Membrane-associated sphingomyelinase derived from ox brain, its separation process and sphingomyelinase-resisting monoclonal antibody |
| 09/24/2002 | US6455686 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 09/24/2002 | US6455683 Nucleotidesequences coding protein for use in the prevetion and treatment of infectious, inflammatory and allergic diseases |
| 09/24/2002 | US6455678 Human hematopoietic stem and progenitor cell antigen |
| 09/24/2002 | US6455677 FAPα-specific antibody with improved producibility |
| 09/24/2002 | US6455674 Polypeptide for use in the diagnosis and treatment of tissue oxygenation defects |
| 09/24/2002 | US6455673 Polypeptide for use as vaccine in prevention of microorganismal infections |
| 09/24/2002 | US6455498 Structural alterations of the EGF receptor genes in human tumors |
| 09/24/2002 | US6455492 Hepatitis E virus vaccine and method |
| 09/24/2002 | US6455305 Nucleotide sequence of gene involved in cancer; anticarcinogenic agents |
| 09/24/2002 | US6455296 Isolated gene coding polypeptide |
| 09/24/2002 | US6455291 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/24/2002 | US6455290 Tankyrase homolog protein (THP), nucleic acids, and methods related to the same |
| 09/24/2002 | US6455289 Amino acid sequence of enzyme; for preparation of ligands of l-selectin |
| 09/24/2002 | US6455283 Amino acid sequence of polypeptide; for recombinant cell culture production of this growth factor; anticarcinogenic agents; wound healing agents |
| 09/24/2002 | US6455281 Nucleic acids for identifying anti-fungal agents, and uses related thereto |
| 09/24/2002 | US6455278 Nucleic acid which encodes protein of defined amino acid sequence involved in pain perception; analgesics |
| 09/24/2002 | US6455277 Polynucleotides encoding human glial cell line-derived neurotrophic factor receptor polypeptides |
| 09/24/2002 | US6455267 Methods and kits useful for determining the status of and detecting pancreatic B-cell associated autoimmune diseases |
| 09/24/2002 | US6455266 Receptor for a Bacillus thuringiensis toxin |
| 09/24/2002 | US6455265 Preparing candidate immunogenic agents based on an envelope protein of a pathogenic strain, then selecting a modified polypeptide which induces an immune response against the immunodomnant region of the protein but not the host |
| 09/24/2002 | US6455264 Antibodies and diagnostic methods for the diagnosis of pestiviruses |
| 09/24/2002 | US6455253 Methods and compositions for polypeptide engineering |
| 09/24/2002 | US6455245 For immunoassay detection |
| 09/24/2002 | US6455244 Methods for the detection of antibodies associated with autoimmune disorders and infectious agents employing immunoretroid peptides derived from antigens associated with said disorders and agents |
| 09/24/2002 | US6455047 Methods to improve immunogenicity of antigens and specificity of antibodies |
| 09/24/2002 | US6455044 5c8 antigen |
| 09/24/2002 | US6455043 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody |
| 09/24/2002 | US6455042 Method of treating ulcerative colitis or crohn's disease by administering an antibody toαEβ7 integrin |
| 09/24/2002 | US6455040 Sometimes referred to as ?tnfr-5? or ?tr5,? and now referred to hereinafter as ?trail receptor without intracellular domain? or ?trid.? |
| 09/24/2002 | US6455039 An isolated nucleic acid molecule that hybridizes under stringent hybridization conditions with macrophase migration inhibiatory factor (mif) gene selected from dirofilaria immitis mif gene and onchocerca volvulus mif gene |
| 09/24/2002 | CA2105282C Preparation of factor ix |
| 09/24/2002 | CA2065325C Cdr grafted anti-cea antibodies and their production |
| 09/20/2002 | CA2715100A1 A novel receptor trem(triggering receptor expressed on myeloid cells) and uses thereof |
| 09/19/2002 | WO2002072888A2 Polymorphisms in the human cmoat gene and uses thereof |
| 09/19/2002 | WO2002072832A2 Therapeutic binding molecules |
| 09/19/2002 | WO2002072830A2 Proteins associated with cell growth, differentiation, and death |
| 09/19/2002 | WO2002072822A2 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 09/19/2002 | WO2002072794A2 Immunoglobulin superfamily proteins |
| 09/19/2002 | WO2002072790A2 Tsg101-gag interaction and use thereof |
| 09/19/2002 | WO2002072788A2 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses |
| 09/19/2002 | WO2002072769A2 Human serpin polypeptides |
| 09/19/2002 | WO2002072752A2 Forms of prostate specific antigens and methods for their detection |
| 09/19/2002 | WO2002072637A1 Natural antibodie active against hiv virus |
| 09/19/2002 | WO2002072636A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 09/19/2002 | WO2002072635A2 Specific binding members |
| 09/19/2002 | WO2002072632A2 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. |
| 09/19/2002 | WO2002072630A2 Nucleic acid-associated proteins |
| 09/19/2002 | WO2002072628A1 Physiologically active polypeptide and polynucleotide encoding the same |
| 09/19/2002 | WO2002072626A2 Novel form of the phgpx protein as a diagnostic marker for male infertility |
| 09/19/2002 | WO2002072608A2 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW-AFFINITY FCηRECEPTORS |
| 09/19/2002 | WO2002072605A2 Expression technology for proteins containing a hybrid isotype antibody moiety |
| 09/19/2002 | WO2002072600A2 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| 09/19/2002 | WO2002072596A1 Steap-related protein |
| 09/19/2002 | WO2002072141A2 Targeted ligands |
| 09/19/2002 | WO2002072030A2 High affinity integrin polypeptides and uses thereof |
| 09/19/2002 | WO2002072008A2 Method for treating cancer using a33 specific antibodies and chemotherapeutic agents |
| 09/19/2002 | WO2002050119A3 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 09/19/2002 | WO2002033119A9 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 09/19/2002 | WO2002033079A3 Human g-protein coupled receptor and uses thereof |
| 09/19/2002 | WO2002032940A3 Osteopontin-coated surfaces and methods of use |
| 09/19/2002 | WO2002022871A3 Polymorphic bone morphogenetic protein 2 |
| 09/19/2002 | WO2002018553A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/19/2002 | WO2002017949A9 Novel functions for dp214 |
| 09/19/2002 | WO2002014355A3 Novel mitogen activated kinase |
| 09/19/2002 | WO2002012456A3 Ampk-related serine/threonine kinase, designated snark |
| 09/19/2002 | WO2002004664A9 Genes comprising coding mononucleotide microsatellites or dinucleotide microsatellites that can be isolated from tumour cells |
| 09/19/2002 | WO2002002610A3 Secretion and trafficking molecules |
| 09/19/2002 | WO2001092525A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/19/2002 | WO2001088162A3 Methods and vectors for generating antibodies in avian species and uses therefor |
| 09/19/2002 | WO2001085956A3 Lipid metabolism enzymes |
| 09/19/2002 | WO2001083783A3 In vivo loading of mhc |
| 09/19/2002 | WO2001083514A3 Nucleic acids encoding a regulator of a g protein signaling, rgs18, and uses thereof |
| 09/19/2002 | WO2001066740A3 Compositions and methods for the treatment of immune related diseases |
| 09/19/2002 | WO2001036630A9 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 09/19/2002 | WO2001007483A9 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein |
| 09/19/2002 | WO1997046589A3 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
| 09/19/2002 | US20020133001 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 09/19/2002 | US20020133000 Neuronal protein for use in inducing sleep and for treatment of sleep disorders |
| 09/19/2002 | US20020132997 Nucleotide sequences coding enzymatic polypeptide for use as amplification tool in genetic engineering |
| 09/19/2002 | US20020132990 Bioengineered vehicles for targeted nucleic acid delivery |
| 09/19/2002 | US20020132989 Kit for determining DNA double-stranded breaks with anti-gamma-H2A antibodies |
| 09/19/2002 | US20020132988 Generation preferential antibody; construct peptide library, immunize cells, isolating and purify antisera from cells |
| 09/19/2002 | US20020132987 Methods and compositions for neural progenitor cells |
| 09/19/2002 | US20020132983 Antibodies as chimeric effector cell receptors against tumor antigens |
| 09/19/2002 | US20020132981 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/19/2002 | US20020132979 Monoclonal antibody for use in the diagnosis, prevention and treatment of tumors |
| 09/19/2002 | US20020132978 VEGF-modulated genes and methods employing them |
| 09/19/2002 | US20020132778 Modulating angiogenesis |
| 09/19/2002 | US20020132775 Human potassium channel 1 and 2 proteins |
| 09/19/2002 | US20020132771 Binding agent that specifically binds to both soluble and tumor-bound tumor- associated MUC-1 and that is effective in therapeutically treating a mammal having a tumor that expresses a tumor- associated MUC-1. |
| 09/19/2002 | US20020132768 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/19/2002 | US20020132370 Detection of a blood coagulation activity marker in a body fluid sample |
| 09/19/2002 | US20020132330 Polypeptide for use in the treatment, prevention and diagnosis of inflammation, cell proliferation and apoptosis |
| 09/19/2002 | US20020132324 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |